Glucocorticoid use and risk of first and recurrent venous thromboembolism: self‐controlled case‐series and cohort study

Glucocorticoid treatment increases venous thromboembolism (VTE) risk. Whether this is due to the medication or the underlying disease, or affects the risk of VTE recurrence, has been difficult to determine. The aim of our present study was to quantify the risk for first and recurrent VTE associated...

Descripción completa

Detalles Bibliográficos
Autores principales: Orsi, Fernanda A., Lijfering, Willem M., Geersing, Geert‐Jan, Rosendaal, Frits R., Dekkers, Olaf M., le Cessie, Saskia, Cannegieter, Suzanne C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Platelets, Thrombosis and Haemostasis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8251551/
https://www.ncbi.nlm.nih.gov/pubmed/33748963
http://dx.doi.org/10.1111/bjh.17388

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8251551/
https://www.ncbi.nlm.nih.gov/pubmed/33748963
http://dx.doi.org/10.1111/bjh.17388

Ejemplares similares